{
    "organizations": [],
    "uuid": "b349aa13e3d6953300670db64878521918061f38",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-kuros-biosciences-expands-license/brief-kuros-biosciences-expands-license-agreement-with-checkmate-idUSFWN1P2018",
    "ord_in_thread": 0,
    "title": "BRIEF-Kuros Biosciences: Expands License Agreement With Checkmate",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 8 (Reuters) - KUROS BIOSCIENCES AG:\n* EXPANDS LICENSE AGREEMENT WITH CHECKMATE * KUROS BIOSCIENCES - AMENDMENT EXTENDS FIELD FROM ONCOLOGY TO ALL INDICATIONS AND BROADENS RANGE OF PRODUCT CANDIDATES COVERED Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-01-08T14:04:00.000+02:00",
    "crawled": "2018-01-09T17:18:58.017+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "kuros",
        "bioscience",
        "ag",
        "expands",
        "license",
        "agreement",
        "checkmate",
        "kuros",
        "bioscience",
        "amendment",
        "extends",
        "field",
        "oncology",
        "indication",
        "broadens",
        "range",
        "product",
        "candidate",
        "covered",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}